CAR-GPRC5D
- Generic Name
- CAR-GPRC5D
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Phase 1
Recruiting
- Conditions
- Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia
- Interventions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05759793
- Locations
- 🇨🇳
Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath